Michael Scolaro

Michael Scolaro

Sep 08, 2017

Group 6 Copy 170
-1
Please wait...

About This Project

We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Blast off!

Browse Other Projects on Experiment

Related Projects

Personalized Cancer and Viral Therapy: Clostridium-based Cell Delivery System coupled to CRISPR/Cas9 Nanotherapeutic

One of the fundamental weaknesses in cancer treatment or any therapy based at the cellular level is entering...

Gila monster genomics: conservation, venom, and treatments for Type-II diabetes

The Gila monster, with its distinctive black and orange pattern, is one of Arizona’s most iconic animals...

Are coyotes contributing to the spread Rocky Mountain spotted fever in Arizona?

Rocky Mountain spotted fever (RMSF) is a tick-borne bacterial infection that can cause permanent disability...

Backer Badge Funded